Invivyd Inc has a consensus price target of $7.8, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Guggenheim on May 24, 2024, May 14, 2024, and April 5, 2024. With an average price target of $13 between HC Wainwright & Co., HC Wainwright & Co., and Guggenheim, there's an implied 1092.66% upside for Invivyd Inc from these 3 analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/24/2024 | Buy Now | 1276.15% | HC Wainwright & Co. | Patrick Trucchio | → $15 | Reiterates | Buy → Buy | Get Alert |
05/14/2024 | Buy Now | 1276.15% | HC Wainwright & Co. | Patrick Trucchio | → $15 | Reiterates | Buy → Buy | Get Alert |
04/05/2024 | Buy Now | 725.69% | Guggenheim | Evan Wang | → $9 | Upgrade | Neutral → Buy | Get Alert |
03/26/2024 | Buy Now | 817.43% | Morgan Stanley | Maxwell Skor | $4 → $10 | Upgrade | Equal-Weight → Overweight | Get Alert |
03/25/2024 | Buy Now | 1276.15% | HC Wainwright & Co. | Patrick Trucchio | → $15 | Reiterates | Buy → Buy | Get Alert |
01/18/2024 | Buy Now | 1276.15% | HC Wainwright & Co. | Patrick Trucchio | $5 → $15 | Maintains | Buy | Get Alert |
12/19/2023 | Buy Now | 266.97% | Morgan Stanley | Jeffrey Hung | $1 → $4 | Upgrade | Underweight → Equal-Weight | Get Alert |
08/14/2023 | Buy Now | 358.72% | HC Wainwright & Co. | Patrick Trucchio | → $5 | Reiterates | Buy → Buy | Get Alert |
07/18/2023 | Buy Now | 358.72% | HC Wainwright & Co. | Patrick Trucchio | → $5 | Reiterates | Buy → Buy | Get Alert |
06/23/2023 | Buy Now | 358.72% | HC Wainwright & Co. | Patrick Trucchio | → $5 | Reiterates | Buy → Buy | Get Alert |
05/15/2023 | Buy Now | 358.72% | HC Wainwright & Co. | Patrick Trucchio | → $5 | Reiterates | Buy → Buy | Get Alert |
05/01/2023 | Buy Now | 358.72% | HC Wainwright & Co. | Patrick Trucchio | → $5 | Initiates | → Buy | Get Alert |
03/27/2023 | Buy Now | -8.26% | Morgan Stanley | Matthew Harrison | $2 → $1 | Maintains | Underweight | Get Alert |
01/24/2023 | Buy Now | 83.49% | Morgan Stanley | Matthew Harrison | $3 → $2 | Maintains | Underweight | Get Alert |
09/14/2022 | Buy Now | 175.23% | Morgan Stanley | Matthew Harrison | → $3 | Maintains | Underweight | Get Alert |
The latest price target for Invivyd (NASDAQ:IVVD) was reported by HC Wainwright & Co. on May 24, 2024. The analyst firm set a price target for $15.00 expecting IVVD to rise to within 12 months (a possible 1276.15% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Invivyd (NASDAQ:IVVD) was provided by HC Wainwright & Co., and Invivyd reiterated their buy rating.
The last upgrade for Invivyd Inc happened on April 5, 2024 when Guggenheim raised their price target to $9. Guggenheim previously had a neutral for Invivyd Inc.
There is no last downgrade for Invivyd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Invivyd, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Invivyd was filed on May 24, 2024 so you should expect the next rating to be made available sometime around May 24, 2025.
While ratings are subjective and will change, the latest Invivyd (IVVD) rating was a reiterated with a price target of $15.00 to $15.00. The current price Invivyd (IVVD) is trading at is $1.09, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.